US2016287541A1PendingUtilityA1

Modified Release Tranexamic Acid Formulation

Assignee: ACTAVIS INCPriority: Nov 30, 2010Filed: Jun 15, 2016Published: Oct 6, 2016
Est. expiryNov 30, 2030(~4.4 yrs left)· nominal 20-yr term from priority
A61K 9/2846A61K 9/2027A61P 7/04A61K 9/2009A61K 9/2054A61K 31/195A61K 9/2077A61K 9/2013
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A modified release dosage form for the oral administration of tranexamic acid.

Claims

exact text as granted — not AI-modified
1 - 24 . (canceled) 
     
     
         25 . A modified release dosage form consisting essentially of:
 (A) a compressed matrix core which comprises:
 (i) tranexamic acid; 
 (ii) a release controlling material; and 
 (iii) a tableting excipient selected from the group consisting of binders, fillers, disintegrants, glidants, lubricants or mixtures thereof; 
   (B) a functional coating applied to and surrounding the compressed matrix core which comprises:
 (i) a coating agent which is insoluble in water but soluble in aqueous media with a pH below 4; and 
 (ii) a processing aid selected from the group consisting of a binder, filler, pigment, lubricant, plasticizer and mixtures thereof; and 
   (C) optionally an aesthetic coating.   
     
     
         26 . The modified release dosage form as defined in  claim 25  wherein the dosage form is a tablet or mini tablet. 
     
     
         27 . The modified release dosage form as defined in  claim 25  wherein the coating agent which is insoluble in water but soluble in aqueous media with a pH below 4 is an aminoalkyl methacrylate copolymer. 
     
     
         28 . The modified release dosage form as defined in  claim 25  wherein the compressed matrix core has a hardness of 13-20 kp. 
     
     
         29 . A modified release tablet consisting essentially of:
 (A) a compressed matrix core which comprises:
 (i) tranexamic acid; 
 (ii) a release controlling material; and 
 (iii) a tableting excipient selected from the group consisting of binders, fillers, disintegrants, glidants, lubricants or mixtures thereof; 
   (B) a functional coating applied to and surrounding the compressed matrix core which comprises:
 (i) an aminoalkyl methacrylate copolymer that is insoluble in water but soluble in aqueous media with a pH below 4; and 
 (ii) a processing aid selected from the group consisting of a binder, filler, pigment, lubricant, plasticizer and mixtures thereof; and 
   (C) optionally an aesthetic coating, wherein the compressed matrix core has a hardness of 13-20 kp.

Join the waitlist — get patent alerts

Track US2016287541A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.